Literature DB >> 4538724

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

R D Soloway, W H Summerskill, A H Baggenstoss, M G Geall, G L Gitnićk, I R Elveback, L J Schoenfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4538724

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  165 in total

Review 1.  Autoimmune hepatitis.

Authors:  E A Roberts
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  Editorial: Chronic hepatitis--1975.

Authors:  W H Summerskill
Journal:  Am J Dig Dis       Date:  1975-11

3.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors: 
Journal:  Am J Dig Dis       Date:  1975-06

4.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 5.  Do we need alternative treatment options for autoimmune hepatitis?

Authors:  Antal Csepregi; Peter Malfertheiner
Journal:  Curr Gastroenterol Rep       Date:  2006-06

6.  Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection.

Authors:  Reiichiro Kuwahara; Hiroki Saitsu; Mitsuhiko Abe; Akio Takata; Kazuo Tanaka; Teruko Hino; Tatsuya Ide; Ryoko Kuromatsu; Ken Tanikawa; Masayoshi Kage; Ryukichi Kumashiro; Michio Sata
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

7.  Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.

Authors:  S Bar-Meir; Z Halpern; M Gutman; Z Shpirer; M Baratz; D Bass
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

8.  Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.

Authors:  Y Yamanishi; Y Nosaka; H Kawasaki; C Hirayama; S Ikawa
Journal:  Gastroenterol Jpn       Date:  1985-06

9.  Prognosis and life expectancy in chronic liver disease.

Authors:  A Propst; T Propst; G Zangerl; D Ofner; G Judmaier; W Vogel
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

10.  Abnormal aminopyrine metabolism in patients with chronic hepatitis.

Authors:  G W Hepner; E Piken; J Lechago
Journal:  West J Med       Date:  1981-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.